Literature DB >> 5369696

The present status of cancer chemotherapy--a summary of papers delivered at the Cherry Hill Conference on "a critical evaluation of cancer chemotherapy".

H G Mandel, D P Rall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5369696

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  3 in total

1.  GIV/Girdin is a rheostat that fine-tunes growth factor signals during tumor progression.

Authors:  Pradipta Ghosh; Mikel Garcia-Marcos; Marilyn G Farquhar
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

2.  A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate.

Authors:  Pradipta Ghosh; Anthony O Beas; Scott J Bornheimer; Mikel Garcia-Marcos; Erin P Forry; Carola Johannson; Jason Ear; Barbara H Jung; Betty Cabrera; John M Carethers; Marilyn G Farquhar
Journal:  Mol Biol Cell       Date:  2010-05-12       Impact factor: 4.138

3.  A study of the immunosuppressive activity of methylene dimethane sulphonate (MDMS) in relation to its effectiveness as an anti-tumour agent.

Authors:  B W Fox; C J Gregory
Journal:  Br J Cancer       Date:  1972-04       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.